あすか製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4886/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/11/18 | 日証協 | 128,828株 | +5.01% | 43,087株 | -2.61% | 215,331株 | +1.65% | 13,383株 | +21.85% |
2022/11/11 | 日証協 | 122,677株 | -1.57% | 44,242株 | -24.26% | 211,839株 | -0.47% | 10,983株 | -58.68% |
2022/11/04 | 日証協 | 124,628株 | +10.7% | 58,410株 | +58.61% | 212,840株 | +7.63% | 26,583株 | +121.84% |
2022/10/28 | 日証協 | 112,577株 | -5.46% | 36,826株 | +8.22% | 197,757株 | -3.93% | 11,983株 | +49.79% |
2022/10/21 | 日証協 | 119,077株 | -6% | 34,029株 | -64.11% | 205,851株 | -3.02% | 8,000株 | -34.89% |
2022/10/14 | 日証協 | 126,677株 | +78.04% | 94,815株 | +33.92% | 212,264株 | -0.69% | 12,286株 | -76.51% |
2022/10/07 | 日証協 | 71,152株 | +26.04% | 70,800株 | -9% | 213,747株 | +134.11% | 52,304株 | -76.45% |
2022/09/30 | 日証協 | 56,452株 | -57.92% | 77,804株 | +34.4% | 91,303株 | -59.51% | 222,092株 | +1064.37% |
2022/09/22 | 日証協 | 134,143株 | -5.24% | 57,888株 | -31.1% | 225,523株 | +0.53% | 19,074株 | -4.55% |
2022/09/16 | 日証協 | 141,567株 | -11.78% | 84,012株 | +14.48% | 224,332株 | -5.53% | 19,983株 | -70.17% |
2022/09/09 | 日証協 | 160,467株 | +1.47% | 73,387株 | +361.06% | 237,474株 | +7.48% | 66,985株 | +287.51% |
2022/09/02 | 日証協 | 158,141株 | -20.48% | 15,917株 | -83.32% | 220,955株 | -4.56% | 17,286株 | -1.14% |
2022/08/26 | 日証協 | 198,858株 | +22.49% | 95,417株 | +17.93% | 231,502株 | +5.23% | 17,486株 | -66.19% |
2022/08/19 | 日証協 | 162,341株 | +6.56% | 80,908株 | +65.85% | 219,991株 | +6.71% | 51,713株 | -24.79% |
2022/08/12 | 日証協 | 152,341株 | -12.92% | 48,783株 | +81.53% | 206,167株 | -4.54% | 68,758株 | +164.5% |
2022/08/05 | 日証協 | 174,941株 | -2.38% | 26,873株 | -2.28% | 215,976株 | -9.07% | 25,995株 | -17.88% |
2022/07/29 | 日証協 | 179,214株 | +12.42% | 27,500株 | +91.5% | 237,512株 | +10.54% | 31,654株 | -2.56% |
2022/07/22 | 日証協 | 159,417株 | -10.36% | 14,360株 | -50.82% | 214,863株 | -9.02% | 32,487株 | -47.7% |
2022/07/15 | 日証協 | 177,833株 | -9.51% | 29,200株 | -9.03% | 236,177株 | -4.42% | 62,111株 | +30.47% |
※株式分割は考慮していませんのでご注意ください。
Page Top